TY - JOUR
T1 - Epidemiology and surveillance of human (neuro)cysticercosis in Europe
T2 - is enhanced surveillance required?
AU - Abraham, Annette
AU - Schmidt, Veronika
AU - Kaminski, Miriam
AU - Stelzle, Dominik
AU - De Meijere, Robert
AU - Bustos, Javier
AU - Soumyaranjan Sahu, Priyadarshi
AU - Hugo Garcia, Hector
AU - Bobić, Branko
AU - Cretu, Carmen
AU - Chiodini, Peter
AU - Deksne, Gunita
AU - Dermauw, Veronique
AU - Devleesschauwer, Brecht
AU - Dorny, Pierre
AU - Fonseca, Ana
AU - Gabriël, Sarah
AU - Ángeles Gómez Morales, Maria
AU - Kucsera, István
AU - Laranjo-González, Minerva
AU - Trevisan, Chiara
AU - Vilhena, Manuela
AU - Walker, Naomi F
AU - Zammarchi, Lorenzo
AU - Sylvia Winkler, Andrea
PY - 2020/5/1
Y1 - 2020/5/1
N2 - OBJECTIVES: To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area, and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000-2016.METHODS: (N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians, and a search for relevant "International Statistical Classification of Diseases and Related Health Problems" (ICD)-based data.RESULTS: Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3,489 cases (N)CC cases were coded: 832 in Italy, 8 in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden.CONCLUSION: Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.
AB - OBJECTIVES: To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area, and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000-2016.METHODS: (N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians, and a search for relevant "International Statistical Classification of Diseases and Related Health Problems" (ICD)-based data.RESULTS: Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3,489 cases (N)CC cases were coded: 832 in Italy, 8 in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden.CONCLUSION: Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.
KW - Europe
KW - epidemiology
KW - neurocysticercosis
UR - http://www.scopus.com/inward/record.url?scp=85082710866&partnerID=8YFLogxK
U2 - 10.1111/tmi.13384
DO - 10.1111/tmi.13384
M3 - Article
C2 - 32083787
SN - 1360-2276
VL - 25
SP - 566
EP - 578
JO - Tropical Medicine & International Health
JF - Tropical Medicine & International Health
IS - 5
ER -